Search results

Evidence-based recommendations on adalimumab (Humira) for treating active moderate to severe hidradenitis suppurativa in adults whose disease has not responded to conventional systemic therapy.

Result type

Technology appraisal guidance

Published

22 June 2016

Evidence-based recommendations on supercapsular percutaneously assisted total hip arthroplasty for osteoarthritis in adults. This involves replacing a hip using smaller cuts than are used in standard surgery.

Result type

HealthTech guidance

Published

25 May 2022

Evidence-based recommendations on cytoreduction surgery with hyperthermic intraoperative peritoneal chemotherapy for peritoneal carcinomatosis. This involves surgically removing visible cancer and bathing the abdominal cavity with heated chemotherapy fluid to reach any remaining cancer cells.

Result type

HealthTech guidance

Published

3 March 2021

Evidence-based recommendations on percutaneous deep venous arterialisation for chronic limb-threatening ischaemia. This involves making a hole between a blocked artery and a vein, allowing the blood to flow into the leg beyond the blockage.

Result type

HealthTech guidance

Published

18 October 2023

Evidence-based recommendations on percutaneous mechanical thrombectomy for acute deep vein thrombosis of the leg in adults. This involves removing the clot through a catheter inserted into the vein.

Result type

HealthTech guidance

Published

12 June 2019

Question In adults having primary elective shoulder replacement for pain and functional loss after a previous proximal humeral fracture...

Result type

Research recommendation

Published

10 August 2020

This guideline covers assessing the risk of fragility fracture in people aged 18 and over with osteoporosis. It aims to provide guidance on the selection and use of risk assessment tools in the care of adults at risk of fragility fractures in all NHS settings.

Result type

Clinical guideline

Last updated

7 February 2017

Evidence-based recommendations on afamelanotide (Scenesse) for treating erythropoietic protoporphyria in adults.

Result type

Highly specialised technologies guidance

Published

26 July 2023

Evidence-based recommendations on adalimumab (Humira), etanercept (Enbrel), infliximab (Remicade, Remsima, Inflectra), certolizumab pegol (Cimzia), golimumab (Simponi), tocilizumab (RoActemra) and abatacept (Orencia). These drugs are for adults with severe rheumatoid arthritis who have tried conventional DMARDs only but they have not worked.

Result type

Technology appraisal guidance

Published

26 January 2016

Evidence-based recommendations on endoscopic saphenous vein harvest for coronary artery bypass grafting. This involves removing the vein under endoscopic guidance through a small cut near the knee (keyhole surgery).

Result type

HealthTech guidance

Published

25 June 2014

NICE has developed a medtech innovation briefing (MIB) on cyanoacrylate glue for hernia mesh fixation .

Result type

Medtech innovation briefing

Published

5 July 2022

Evidence-based recommendations on upadacitinib (Rinvoq) for treating moderate active rheumatoid arthritis in adults.

Result type

Technology appraisal guidance

Published

10 November 2021

Evidence-based recommendations on enzalutamide (Xtandi) for treating metastatic hormone-relapsed prostate cancer in adults who have had treatment with docetaxel-containing chemotherapy.

Result type

Technology appraisal guidance

Published

23 July 2014

NICE has developed a medtech innovation briefing (MIB) on Mobi-C for cervical disc replacement

Result type

Medtech innovation briefing

Published

28 June 2016

Evidence-based recommendations on laparoscopic mobilisation of the greater omentum for breast reconstruction. This involves removing the fatty tissue using special instruments through small cuts in the abdomen.

Result type

HealthTech guidance

Published

27 February 2008